Insight Molecular Diagnostics (IMDX) Other Non Operating Income (2015 - 2026)

Insight Molecular Diagnostics has disclosed Other Non Operating Income across 12 years of filings, most recently posting $146000.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $146000.0, down 7.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 114.59% YoY), and the FY2025 annual result was $1.0 million, up 118.83% from the prior year.
• Other Non Operating Income came in at $146000.0 for Q1 2026 at Insight Molecular Diagnostics, down from $506000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $506000.0 in Q4 2025 to a low of -$371000.0 in Q4 2022.
• The 5-year median for Other Non Operating Income is $127000.0 (2023), against an average of $114470.6.
• Across the five-year window, Other Non Operating Income plunged 1900.0% in 2022 and surged 15400.0% in 2024, its largest moves.
• Insight Molecular Diagnostics' Other Non Operating Income stood at -$371000.0 in 2022, then soared by 172.51% to $269000.0 in 2023, then tumbled by 45.72% to $146000.0 in 2024, then surged by 246.58% to $506000.0 in 2025, then tumbled by 71.15% to $146000.0 in 2026.
• The last three Other Non Operating Income figures came in at $146000.0 (Q1 2026), $506000.0 (Q4 2025), and $223000.0 (Q3 2025), per Business Quant data.